Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Psychoactive Substances
UNODC Early Warning Advisory on New Psychoactive Substances
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...
New psychoactive substances (NPS)
Overview A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...
A Case study of the treatment of methamphetamine use disorder amongst medical students in Abia State, Nigeria - Chiamaka R. Nwaoru, Day 5, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022
Psychiatric Co-Morbidity and Substance Use Associated with Medication Adherence Among People Living with HIV, Virology Clinic of University of Port Harcourt Teaching Hospital - Dr Aborlo Kennedy Nkporbu, Day 5, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022.
Evidence for the universal, selective and indicated prevention of illicit substance use based on a systematic review and data science - Orlando Scoppetta, Day 4, 09:00-10:29
Presented as part of the Uniting the global community to face the challenge of addiction event, online on 15th May, 2022
Treatment, Day 3, Track 3, 13:30-15:00
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022
Educational Prevention, Day 3, Track 1, 09:00-10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022
NRC Studies on Stigma and Family, Day 1, Track 2, 15:30-17:00
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 12th May,2022
Opening Ceremony and Keynote Speaker - Professor Michael Farrell, Day 1, Track 1, 09:00 - 10:30
Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 12th May 2022. Opening Ceremony and Keynote Speaker - Professor Michael Farrell Responding to Global Stimulant Use: Challenges and Opportunities
Trends in Cannabis Polysubstance Use During Early Pregnancy Among Patients in a Large Health Care System in Northern California
Abstract Importance Rates of prenatal cannabis use are increasing alongside perceptions that cannabis is a harmless therapeutic for pregnancy-related ailments, while rates of prenatal use of alcohol and tobacco are decreasing. It is...